Thyroid Nodules And Differentiated Thyroid Cancer: Update On The Brazilian Consensus [nódulo Tireoidiano E Câncer Diferenciado De Tireoide: Atualização Do Consenso Brasileiro]

dc.creatorRosario P.W.
dc.creatorWard L.S.
dc.creatorCarvalho G.A.
dc.creatorGraf H.
dc.creatorMaciel R.M.B.
dc.creatorMaciel L.M.Z.
dc.creatorMaia A.L.
dc.creatorVaisman M.
dc.date2013
dc.date2015-06-25T19:14:04Z
dc.date2015-11-26T15:11:50Z
dc.date2015-06-25T19:14:04Z
dc.date2015-11-26T15:11:50Z
dc.date.accessioned2018-03-28T22:21:57Z
dc.date.available2018-03-28T22:21:57Z
dc.identifierArquivos Brasileiros De Endocrinologia E Metabologia. , v. 57, n. 4, p. 240 - 264, 2013.
dc.identifier10.1590/S0004-27302013000400002
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84880000861&partnerID=40&md5=8a9ebde742da13cf3eb0fead2a126bb5
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/89023
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/89023
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1258242
dc.descriptionThyroid nodules are frequent findings, especially when sensitive imaging methods are used. Although thyroid cancer is relatively rare, its incidence is increasing, particularly in terms of small tumors, which have an uncertain clinical relevance. Most patients with differentiated thyroid cancer exhibit satisfactory clinical outcomes when treatment is appropriate, and their mortality rate is similar to that of the overall population. However, relapse occurs in a considerable fraction of these patients, and some patients stop responding to conventional treatment and eventually die from their disease. Therefore, the challenge is how to identify the individuals who require more aggressive disease management while sparing the majority of patients from unnecessary treatments and procedures. We have updated the Brazilian Consensus that was published in 2007, emphasizing the diagnostic and therapeutic advances that the participants, representing several Brazilian university centers, consider most relevant in clinical practice. The formulation of the present guidelines was based on the participants' experience and a review of the relevant literature. © ABE&M todos os direitos reservados.
dc.description57
dc.description4
dc.description240
dc.description264
dc.descriptionvander, J.B., Gaston, E.A., Dawber, T.R., The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy (1968) Ann Intern Med., 69, pp. 537-540
dc.descriptionTunbridge, W.M., Evered, D.C., Hall, R., Appleton, D., Brewis, M., Clark, F., The spectrum of thyroid disease in a community: The Whickham survey (1977) Clin Endocrinol (Oxf)., 7, pp. 481-493
dc.descriptionTan, G.H., Gharib, H., Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging (1997) Ann Intern Med., 126, pp. 226-231
dc.descriptionGuth, S., Theune, U., Aberle, J., Galach, A., Bamberger, C.M., Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination (2009) Eur J Clin Invest., 39, pp. 699-706
dc.descriptionHegedus, L., The thyroid nodule (2004) N Engl J Med., 351, pp. 1764-1771
dc.descriptionDavies, L., Welch, H.G., Increasing incidence of thyroid cancer in the United States, 1973-2002 (2006) JAMA., 295, pp. 2164-2167
dc.descriptionVeiga, L.H., Neta, G., Aschebrook-Kilfoy, B., Ron, E., Devesa, S.S., Thyroid cancer incidence patterns in São Paulo, Brazil and the U.S. SEER program, 1997-2008 (2013) Thyroid, , (in press)
dc.description(2012) Síntese de resultados e comentários: Câncer da glândula tireoide., , http://www.inca.gov.br/estimativa/2012, Instituto Nacional do Câncer José Alencar Gomes da Silva (INCA). Estimativa: incidência de câncer no Brasil. Available at: Access: May 31, 2013
dc.descriptionAssociação Médica Brasileira e Conselho Federal de Medicina., , http://www.projetodiretrizes.org.br/projeto_diretrizes/texto_introdutorio.pdf, Projeto Diretrizes. Available at: Access: May 31, 2013
dc.descriptionTronko, M.D., Howe, G.R., Bogdanova, T.I., Bouville, A.C., Epstein, O.V., Brill, A.B., A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: Thyroid cancer in Ukraine detected during first screening (2006) J Natl Cancer Inst., 98, pp. 897-903
dc.descriptionRaza, S.N., Shah, M.D., Palme, C.E., Hall, F.T., Eski, S., Freeman, J.L., Risk factors for well-differentiated thyroid carcinoma in patients with thyroid nodular disease (2008) Otolaryngol Head Neck Surg., 139, pp. 21-26
dc.descriptionRosário, P.W., Barroso, A.L., Rezende, L.L., Padrão, E.L., Borges, M.A., Guimaraes, V.C., Testicular function after radioiodine therapy in patients with thyroid cancer (2006) Thyroid., 16, pp. 667-670
dc.descriptionSouza Rosário, P.W., Alvarenga Fagundes, T., Villas-Boas Fagundes, A.S., Barroso, A.L., Lamego Rezende, L., Lanza Padrão, E., Ovarian function after radioiodine therapy in patients with thyroid cancer (2005) Exp Clin Endocrinol Diabetes., 113, pp. 331-333
dc.descriptionRosário, P.W., Borges, M.A., Purisch, S., Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity (2008) J Nucl Med., 49, pp. 1776-1782
dc.descriptionRosário, P.W., Fagundes, T.A., Fagundes, A.V., Barroso, A.L., Rezende, L.L., Padrao, E.L., Radioiodine therapy and age at menopause in patients with thyroid cancer (2006) Clin Endocrinol (Oxf)., 64, pp. 225-226
dc.descriptionRosário, P.W., Calsolari, M.R., Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human TSH (2013) Thyroid., 23, pp. 617-619
dc.descriptionRubino, C., de Vathaire, F., Dottorini, M.E., Hall, P., Schvartz, C., Couette, J.E., Second primary malignancies in thyroid cancer patients (2003) Br J Cancer., 89, pp. 1638-1644
dc.descriptionRosário, P.W., Fagundes, T.A., Rezende, L.L., Padrão, E.L., Borges, M.A., Barroso, A.L., Assessing hypothyroidism in the preparation of patients with thyroid cancer: Cardiovascular risk, renal function, drug metabolism, persistence of elevated thyroid-stimulating hormone, and absence from work (2006) Endocrinologist., 16, pp. 25-29
dc.descriptionMallick, U., Harmer, C., Yap, B., Wadsley, J., Clarke, S., Moss, L., Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer (2012) N Engl J Med., 366, pp. 1674-1685
dc.descriptionSchlumberger, M., Catargi, B., Borget, I., Deandreis, D., Zerdoud, S., Bridji, B., Strategies of radioiodine ablation in patients with low-risk thyroid cancer (2012) N Engl J Med., 366, pp. 1663-1673
dc.descriptionHugo, J., Robenshtok, E., Grewal, R., Larson, S.M., Tuttle, R.M., Recombinant human TSH-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence (2012) Thyroid., 22, pp. 1007-1015
dc.descriptionRago, T., Fiore, E., Scutari, M., Santini, F., Di Coscio, G., Romani, R., Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease (2010) Eur J Endocrinol., 162, pp. 763-770
dc.descriptionRosário, P.W., Xavier, A.C., Calsolari, M.R., Recombinant human thyrotropin in thyroid remnant ablation with 131-iodine in high-risk patients (2010) Thyroid., 20, pp. 1247-1252
dc.descriptionRosário, P.W., Mineiro Filho, A.F., Lacerda, R.X., Calsolari, M.R., Longterm follow-up of at least five years after recombinant human thyrotropin compared to levothyroxine withdrawal for thyroid remnant ablation with radioactive iodine (2012) Thyroid., 22, pp. 332-333
dc.descriptionRosário, P.W., Salles, D.S., Purisch, S., Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): Possible implications for tumor growth (2009) Arq Bras Endocrinol Metabol., 53, pp. 767-770
dc.descriptionRosário, P.W., Mineiro Filho, A.F., Lacerda, R.X., Calsolari, M.R., Recombinant human TSH for thyroid remnant ablation with (131)I in children and adolescents with papillary carcinoma (2012) Horm Res Paediatr., 77, pp. 59-62
dc.descriptionRosário, P.W., Reis, J.S., Barroso, A.L., Rezende, L.L., Padrão, E.L., Fagundes, T.A., Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake (2004) Nucl Med Commun., 25, pp. 1077-1081
dc.descriptionBarbaro, D., Grosso, M., Boni, G., Lapi, P., Pasquini, C., Orsini, P., Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: The effect of pre-treatment with furosemide and furosemide plus lithium (2010) Eur J Nucl Med Mol Imaging., 37, pp. 242-249
dc.descriptionRosário, P.W., Xavier, A.C., Recombinant human thyroid stimulating hormone in thyroid remnant ablation with 1.1 GBq 131iodine in low-risk patients (2012) Am J Clin Oncol., 35, pp. 101-104
dc.descriptionYamazaki, C.A., Padovani, R., Biscolla, R.P., Ikejri, E.S., Matsumura, L.K., McIel, R.M., Lithium as an adjuvant in the postoperative ablation of remnant tissue in low risk thyroid carcinoma (2012) Thyroid., 22, pp. 1002-1006
dc.descriptionRosário, P.W., Purisch, S., Vasconcelos, F.P., Padrão, E.L., Rezende, L.L., Barroso, A.L., Long-term recurrence of thyroid cancer after thyroid remnant ablation with 1.1 and 3.7 GBq radioiodine (2007) Nucl Med Commun., 28, pp. 507-508
dc.descriptionTuttle, R.M., Leboeuf, R., Robbins, R.J., Qualey, R., Pentlow, K., Larson, S.M., Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer (2006) J Nucl Med., 47, pp. 1587-1591
dc.descriptionRosario, P.W., Mineiro Filho, A.F., Prates, B.S., Silva, L.C., Lacerda, R.X., Calsolari, M.R., Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma (2012) Thyroid., 22, pp. 805-808
dc.descriptionSawka, A.M., Ibrahim-Zada, I., Galacgac, P., Tsang, R.W., Brierley, J.D., Ezzat, S., Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: A systematic review (2010) Thyroid., 20, pp. 1129-1138
dc.descriptionRosário, P.W., Guimarães, V.C., Maia, F.F., Fagundes, T.A., Purisch, S., Padrão, E.L., Thyroglobulin before ablation and correlation with posttreatment scanning (2005) Laryngoscope., 115, pp. 264-267
dc.descriptionKendler, D.B., Vaisman, F., Corbo, R., Martins, R., Vaisman, M., Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancer (2012) Clin Nucl Med., 37, pp. 545-549
dc.descriptionValadão, M.M., Rosário, P.W., Borges, M.A., Costa, G.B., Rezende, L.L., Padrão, E.L., Positive predictive value of detectable stimulated Tg during the first year after therapy of thyroid cancer and the value of comparison with Tg-ablation and Tg measured after 24 months (2006) Thyroid., 16, pp. 1145-1149
dc.descriptionToubeau, M., Touzery, C., Arveux, P., Chaplain, G., Vaillant, G., Berriolo, A., Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer (2004) J Nucl Med., 45, pp. 988-994
dc.descriptionSouza Rosário, P.W., Barroso, A.L., Rezende, L.L., Padrão, E.L., Fagundes, T.A., Penna, G.C., Post I-131 therapy scanning in patients with thyroid carcinoma metastases: An unnecessary cost or a relevant contribution? (2004) Clin Nucl Med., 29, pp. 795-798
dc.descriptionRosário, P.W., Barroso, A.L., Rezende, L.L., Padrão, E.L., Reis, J.S., Purisch, S., Frequency of nonmetastatic (physiological) uptake on posttreatment scans in patients with differentiated thyroid carcinoma (2007) Endocrinologist., 17, pp. 78-82
dc.descriptionRosário, P.W., Cardoso, L.D., Barroso, A., Padrão, E.L., Rezende, L., Purisch, S., Consequences of the persistence of large thyroid remnants after bilateral thyroidectomy for differentiated thyroid cancer (2004) Arq Bras Endocrinol Metabol., 48, pp. 379-383
dc.descriptionRosário, P., Borges, M., Reis, J., Alves, M.F., Effect of suppressive therapy with levothyroxine on the reduction of serum thyroglobulin after total thyroidectomy (2006) Thyroid., 16, pp. 199-200
dc.descriptionCooper, D.S., Specker, B., Ho, M., Sperling, M., Ladenson, P.W., Ross, D.S., Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry (1998) Thyroid., 8, pp. 737-744
dc.descriptionSoelberg, K.K., Bonnema, S.J., Brix, T.H., Hegedüs, L., Risk of malignancy in thyroid incidentalomas detected by (18)F-Fluorodeoxyglucose Positron Emission Tomography: A systematic review (2012) Thyroid., 22, pp. 918-925
dc.descriptionJonklaas, J., Sarlis, N.J., Litofsky, D., Ain, K.B., Bigos, S.T., Brierley, J.D., Outcomes of patients with differentiated thyroid carcinoma following initial therapy (2006) Thyroid., 16, pp. 1229-1242
dc.descriptionHovens, G.C., Stokkel, M.P., Kievit, J., Corssmit, E.P., Pereira, A.M., Romijn, J.A., Association of serum thyrotropin concentration with recurrence and death in differentiated thyroid cancer (2007) J Clin Endocrinol Metab., 92, pp. 2610-2615
dc.descriptionRosário, P.W., Bone and heart abnormalities of subclinical hyperthyroidism in women below the age of 65 years (2008) Arq Bras Endocrinol Metabol., 52, pp. 1448-1451
dc.descriptionde Martins Almeida, J.F., Gonçalves Tsumura, W., Vaisman, M., Montalli Assumpcao, L.V., Ward, L.S., Current recommendations for levothyroxine treatment of differentiated thyroid cancer patients are not properly implemented in a clinical practice (2012) J Endocrinol Invest., 35, pp. 901-904
dc.descriptionMcIel, R.M., O laboratório no diagnóstico e seguimento de doenças auto-imunes e neoplásicas de tiróide (2002) Arq Bras Endocrinol Metabol., 46, pp. 65-71
dc.descriptionRosário, P.W., Maia, F.F., Fagundes, T.A., Vasconcelos, F.P., Cardoso, L.D., Purisch, S., Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: Methods of detection, interference with serum thyroglobulin measurement and clinical significance (2004) Arq Bras Endocrinol Metabol., 48, pp. 487-492
dc.descriptionBoldarine, V.T., McIel, R.M., Guimarães, G.S., Nakabashi, C.C., Camacho, C.P., Andreoni, D.M., Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma (2010) J Clin Endocrinol Metab., 95, pp. 1726-1733
dc.descriptionRosário, P.W., Furtado, M.D., Filho, A.F., Lacerda, R.X., Calsolari, M.R., Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence (2012) Thyroid., 22, pp. 1165-1169
dc.descriptionMazzaferri, E.L., Robbins, R.J., Spencer, C.A., Braverman, L.E., Pacini, F., Wartofsky, L., A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma (2003) J Clin Endocrinol Metab., 88, pp. 1433-1441
dc.descriptionPacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma (2003) J Clin Endocrinol Metab., 88, pp. 3668-3673
dc.descriptionWong, C.K., Wheeler, M.H., Thyroid nodules: Rational management (2000) World J Surg., 24, pp. 934-941
dc.descriptionMcIel, R.M., Will the thyroglobulin assay with lower functional sensitivity whilst the patients are on L-T4 treatment replace the TSH-stimulated thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer? (2007) Arq Bras Endocrinol Metabol., 51, pp. 862-866
dc.descriptionCastagna, M.G., Tala Jury, H.P., Cipri, C., Belardini, V., Fioravanti, C., Pasqui, L., The use of ultrasensitive thyroglobulin assays reduces but not abolishes the need for TSH stimulation in patients with differentiated thyroid carcinoma (2011) J Endocrinol Invest., 34, pp. e219-e223
dc.descriptionRosário, P.W., Purisch, S., Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays? (2008) Clin Endocrinol., 68, pp. 338-342
dc.descriptionIervasi, A., Iervasi, G., Ferdeghini, M., Solimeo, C., Bottoni, A., Rossi, L., Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer (2007) Clin Endocrinol., 67, pp. 434-441
dc.descriptionRo
dc.descriptionAnil, C., Goksel, S., Gursoy, A., Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: A single-center prospective study (2010) Thyroid., 20, pp. 601-606
dc.descriptionBoelaert, K., Horacek, J., Holder, R.L., Watkinson, J.C., Sheppard, M.C., Franklyn, J.A., Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration (2006) J Clin Endocrinol Metab., 91, pp. 4295-4301
dc.descriptionHaymart, M.R., Repplinger, D.J., Leverson, G.E., Elson, D.F., Sippel, R.S., Jaume, J.C., Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage (2008) J Clin Endocrinol Metab., 93, pp. 809-814
dc.descriptionNiccoli, P., Wion-Barbot, N., Caron, P., Henry, J.F., de Micco, C., Saint Andre, J.P., Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients. The French Medullary Study Group (1997) J Clin Endocrinol Metab., 82, pp. 338-341
dc.descriptionElisei, R., Bottici, V., Luchetti, F., Di Coscio, G., Romei, C., Grasso, L., Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders (2004) J Clin Endocrinol Metab., 89, pp. 163-168
dc.descriptionPapi, G., Corsello, S.M., Cioni, K., Pizzini, A.M., Corrado, S., Carapezzi, C., Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study (2006) J Endocrinol Invest., 29, pp. 427-437
dc.descriptionRosario, P.W., Penna, G.C., Brandão, K., Souza, B.E., Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma (2013) Arq Bras Endocrinol Metabol., , (in press)
dc.descriptionPacini, F., Pinchera, A., Giani, C., Grasso, L., Doveri, F., Baschieri, L., Serum thyroglobulin in thyroid carcinoma and other thyroid disorders (1980) J Endocrinol Invest., 3, pp. 283-292
dc.descriptionHegedus, L., Thyroid ultrasound (2001) Endocrinol Metab Clin North Am., 30, pp. 339-360
dc.descriptionMarqusee, E., Benson, C.B., Frates, M.C., Doubilet, P.M., Larsen, P.R., Cibas, E.S., Usefulness of ultrasonography in the management of nodular thyroid disease (2000) Ann Intern Med., 133, pp. 696-700
dc.descriptionShimamoto, K., Satake, H., Sawaki, A., Ishigaki, T., Funahashi, H., Imai, T., Preoperative staging of thyroid papillary carcinoma with ultrasonography (1998) Eur J Radiol., 29, pp. 4-10
dc.descriptionPeccin, S., de Castro, J.A., Furlanetto, T.W., Furtado, A.P., Brasil, B.A., Czepielewski, M.A., Ultrasonography: Is it useful in the diagnosis of cancer in thyroid nodules? (2002) J Endocrinol Invest., 25, pp. 39-43
dc.descriptionTomimori, E.K., Bisi, H., Medeiros-Neto, G., Camargo, R.Y., Ultrasonographic evaluation of thyroid nodules: Comparison with cytologic and histologic diagnosis (2004) Arq Bras Endocrinol Metabol., 48, pp. 105-113
dc.descriptionCappelli, C., Pirola, I., Cumetti, D., Micheletti, L., Tironi, A., Gandossi, E., Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology? (2005) Clin Endocrinol (Oxf)., 63, pp. 689-693
dc.descriptionChammas, M.C., Gerhard, R., de Oliveira, I.R., Widman, A., de Barros, N., Durazzo, M., Thyroid nodules: Evaluation with power Doppler and duplex Doppler ultrasound (2005) Otolaryngol Head Neck Surg., 132, pp. 874-882
dc.descriptionRosario, P.W., Salles, D.S., Purisch, S., Fine-needle biopsy should be performed in solid hypoechoic thyroid nodules greater than one centimeter even in the absence of suspicious ultrasonographic characteristics (2010) Thyroid., 20, pp. 939-940
dc.descriptionRuss, G., Royer, B., Bigorgne, C., Rouxel, A., Bienvenu, M., Leenhardt, L., Prospective evaluation of thyroid imaging reporting and data system (TI-RADS) on 4550 nodules with and without elastography (2013) Eur J Endocrinol., 168, pp. 649-655
dc.descriptionOliver, C., Vaillant-Lombard, J., Albarel, F., Berbis, J., Veyrières, J.B., Sebag, F., What is the contribution of elastography to thyroid nodules evaluation? (2011) Ann Endocrinol (Paris)., 72, pp. 120-124
dc.descriptionJennings, A., Evaluation of substernal goiters using computed tomography and MR imaging (2001) Endocrinol Metab Clin North Am., 30, pp. 401-414
dc.descriptionVriens, D., de Wilt, J.H., van der Wilt, G.J., Netea-Maier, R.T., Oyen, W.J., de Geus-Oei, L.F., The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: Systematic review and metaanalysis of the literature (2011) Cancer., 117, pp. 4582-4594
dc.descriptionShambaugh III, G.E., Quinn, J.L., Oyasu, R., Freinkel, N., Disparate thyroid imaging. Combined studies with sodium pertechnetate Tc 99m and radioactive iodine (1974) JAMA., 228, pp. 866-869
dc.descriptionRosário, P.W., Salles, D.S., Bessa, B., Purisch, S., Contribution of scintigraphy and ultrasonography to the prediction of malignancy in thyroid nodules with indeterminate cytology (2010) Arq Bras Endocrinol Metabol., 54, pp. 56-59
dc.descriptionRosario, P.W., Salles, D.S., Bessa, B., Purisch, S., Low false-negative rate of cytology in thyroid nodules > 4 cm (2009) Arq Bras Endocrinol Metabol., 53, pp. 1143-1145
dc.descriptionMatos, P.S., Ferreira, A.P.C., Ward, L.S., Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series (2006) Endocr Pathol., 17, pp. 165-174
dc.descriptionIto, Y., Miyauchi, A., Inoue, H., Fukushima, M., Kihara, M., Higashiyama, T., An observational trial for papillary thyroid microcarcinoma in Japanese patients (2010) World J Surg., 34, pp. 28-35
dc.descriptionSugitani, I., Toda, K., Yamada, K., Yamamoto, N., Ikenaga, M., Fujimoto, Y., Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: Our treatment strategies and outcomes (2010) World J Surg., 34, pp. 1222-1231
dc.descriptionCibas, E.S., Ali, S.Z., The Bethesda system for reporting thyroid cytopathology (2009) Thyroid., 19, pp. 1159-1165
dc.descriptionKwak, J.Y., Kim, E.K., Kim, H.J., Kim, M.J., Son, E.J., Moon, H.J., How to combine ultrasound and cytological information in decision making about thyroid nodules (2009) Eur Radiol., 19, pp. 1923-1931
dc.descriptionRosario, P.W., Purisch, S., Ultrasonographic characteristics as a criterion for repeat cytology in benign thyroid nodules (2010) Arq Bras Endocrinol Metabol., 54, pp. 52-55
dc.descriptionMaia, F.F., Matos, P.S., Pavin, E.J., Vassallo, J., Zantut-Wittmann, D.E., Value of repeat ultrasound-guided fine-needle aspiration in thyroid nodule with a first benign cytologic result: Impact of ultrasound to predict malignancy (2011) Endocrine., 40, pp. 290-296
dc.descriptionMatos, P.S., Ferreira, A.P., Facuri, F.O., Assumpcao, L.V.M., Metze, K., Ward, L.S., Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy (2005) Histopathology, 47, pp. 391-401
dc.descriptionSaleh, H.A., Feng, J., Tabassum, F., Al-Zohaili, O., Husain, M., Giorgadze, T., Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy (2009) Cytojournal., 6, p. 18
dc.descriptionNikiforov, Y.E., Ohori, N.P., Hodak, S.P., Carty, S.E., LeBeau, S.O., Ferris, R.L., Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: A prospective analysis of 1056 FNA samples (2011) J Clin Endocrinol Metab., 96, pp. 3390-3397
dc.descriptionFerraz, C., Eszlinger, M., Paschke, R., Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules (2011) J Clin Endocrinol Metab., 96, pp. 2016-2026
dc.descriptionShen, R., Liyanarachchi, S., Li, W., Wakely Jr., P.E., Saji, M., Huang, J., MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases (2012) Thyroid., 22, pp. 9-16
dc.descriptionAlexander, E.K., Kennedy, G.C., Baloch, Z.W., Cibas, E.S., Chudova, D., Diggans, J., Preoperative diagnosis of benign thyroid nodules with indeterminate cytology (2012) N Engl J Med., 367, pp. 705-715
dc.descriptionMestman, J.H., Goodwin, T.M., Montoro, M.M., Thyroid disorders of pregnancy (1995) Endocrinol Metab Clin North Am., 24, pp. 41-71
dc.descriptionMoosa, M., Mazzaferri, E.L., Outcome of differentiated thyroid cancer diagnosed in pregnant women (1997) J Clin Endocrinol Metab., 82, pp. 2862-2866
dc.descriptionCastro, M.R., Caraballo, P.J., Morris, J.C., Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: A meta-analysis (2002) J Clin Endocrinol Metab., 87, pp. 4154-4159
dc.descriptionSdano, M.T., Falciglia, M., Welge, J.A., Steward, D.L., Efficacy of thyroid hormone suppression for benign thyroid nodules: Meta-analysis of randomized trials (2005) Otolaryngol Head Neck Surg., 133, pp. 391-396
dc.descriptionYousef, A., Clark, J., Doi, S.A., Thyroxine suppression therapy for benign, non-functioning solitary thyroid nodules: A quality-effects meta-analysis (2010) Clin Med Res., 8, pp. 150-158
dc.descriptionBiondi, B., Cooper, D.S., The clinical significance of subclinical thyroid dysfunction (2008) Endocr Rev., 29, pp. 76-131
dc.descriptionSouza Rosário, P.W., Borges, M.A.R., Vasconcelos, F.P., Gatti, M.F., Purisch, S., Padrão, E.L., Safety of suppressive therapy with levothyroxine: Effects on bone metabolism and cardiac function and morphology and potential benefits of the use of alendronate and [beta]-blockers (2007) Endocrinologist., 17, pp. 148-151
dc.descriptionSchrut, G.C., Miasaki, F.Y., Paz-Filho, G., Cavalcanti, T.C., Graf, H., de Carvalho, G.A., Changes associated with percutaneous ethanol injection in the treatment of thyroid nodules (2011) Endocr Pathol., 22, pp. 79-85
dc.descriptionBonnema, S.J., Fast, S., Hegedüs, L., Non-surgical approach to the benign nodular goiter: New opportunities by recombinant human TSH-stimulated 131I-therapy (2011) Endocrine., 40, pp. 344-353
dc.descriptionGraf, H., Fast, S., Pacini, F., Pinchera, A., Leung, A., Vaisman, M., Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: Results from a multicenter international, randomized, placebo-controlled study (2011) J Clin Endocrinol Metab., 96, pp. 1368-1376
dc.descriptionAlbino, C.C., Mesa Jr., C.O., Olandoski, M., Ueda, C.E., Woellner, L.C., Goedert, C.A., Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine (2005) J Clin Endocrinol Metab., 90, pp. 2775-2780
dc.descriptionRosario, P.W., Salles, D.S., Bessa, B., Purisch, S., Nodular thyroid disease: Natural history of nodules without an initial indication for cytology (2010) Endocrinologist., 20, pp. 243-244
dc.descriptionChung, J., Youk, J.H., Kim, J.A., Kwak, J.Y., Kim, E.K., Ryu, Y.H., Initially non-diagnostic ultrasound-guided fine needle aspiration cytology of thyroid nodules: Value and management (2012) Acta Radiol., 53, pp. 168-173
dc.descriptionMoon, H.J., Kwak, J.Y., Choi, Y.S., Kim, E.K., How to manage thyroid nodules with two consecutive non-diagnostic results on ultrasonography-guided fine-needle aspiration (2012) World J Surg., 36, pp. 586-592
dc.descriptionAlexander, E.K., Hurwitz, S., Heering, J.P., Benson, C.B., Frates, M.C., Doubilet, P.M., Natural history of benign solid and cystic thyroid nodules (2003) Ann Intern Med., 138, pp. 315-318
dc.descriptionMazzaferri, E.L., Kloos, R.T., Current approaches to primary therapy for papillary and follicular thyroid cancer (2001) J Clin Endocrinol Metab., 86, pp. 1447-1463
dc.descriptionIto, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Preoperative ultrasonographic examination for lymph node metastasis: Usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid (2004) World J Surg., 28, pp. 498-501
dc.descriptionKing, A.D., Ahuja, A.T., To, E.W., Tse, G.M., Metreweli, C., Staging papillary carcinoma of the thyroid: Magnetic resonance imaging vs. ultrasound of the neck (2000) Clin Radiol., 55, pp. 222-226
dc.descriptionKoike, E., Yamashita, H., Noguchi, S., Ohshima, A., Watanabe, S., Uchino, S., Bronchoscopic diagnosis of thyroid cancer with laryngotracheal invasion (2001) Arch Surg., 136, pp. 1185-1189
dc.descriptionPadovani, R.P., Kasamatsu, T.S., Nakabashi, C.C., Camacho, C.P., Andreoni, D.M., Malouf, E.Z., One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy (2012) Thyroid., 22, pp. 926-930
dc.descriptionSchlumberger, M.J., Papillary and follicular thyroid carcinoma (1998) N Engl J Med., 338, pp. 297-306
dc.descriptionBaudin, E., Travagli, J.P., Ropers, J., Mancusi, F., Bruno-Bossio, G., Caillou, B., Microcarcinoma of the thyroid gland: The Gustave-Roussy Institute experience (1998) Cancer., 83, pp. 553-559
dc.descriptionRosario, P.W., Fagundes, T.A., Purisch, S., Treatment of papillary microcarcinoma of the thyroid (2004) Arq Bras Endocrinol Metabol., 48, pp. 855-860
dc.descriptionHay, I.D., Hutchinson, M.E., Gonzalez-Losada, T., McIver, B., Reinalda, M.E., Grant, C.S., Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period (2008) Surgery., 144, pp. 980-987
dc.descriptionGrebe, S.K., Hay, I.D., Thyroid cancer nodal metastases: Biologic significance and therapeutic considerations (1996) Surg Oncol Clin N Am., 5, pp. 43-63
dc.descriptionKouvaraki, M.A., Shapiro, S.E., Fornage, B.D., Edeiken-Monro, B.S., Sherman, S.I., Vassilopoulou-Sellin, R., Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer (2003) Surgery., 134, pp. 946-954. , discussion 54-5
dc.descriptionLundgren, C.I., Hall, P., Dickman, P.W., Zedenius, J., Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study (2006) Cancer., 106, pp. 524-531
dc.descriptionTeixeira, G., Teixeira, T., Gubert, F., Chikota, H., Tufano, R., The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0 (2011) Surgery., 150, pp. 1161-1167
dc.descriptionChow, S.M., Law, S.C., Chan, J.K., Au, S.K., Yau, S., Lau, W.H., Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality (2003) Cancer., 98, pp. 31-40
dc.descriptionWada, N., Duh, Q.Y., Sugino, K., Iwasaki, H., Kameyama, K., Mimura, T., Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection (2003) Ann Surg., 237, pp. 399-407
dc.descriptionRosário, P.W., Fagundes, T.A., Padrão, E.L., Rezende, L.L., Barroso, A.L., Total thyroidectomy and lymph node dissection in patients with papillary thyroid carcinoma (2004) Arch Surg., 139, p. 1385
dc.descriptionFilho, J.G., Kowalski, L.P., Postoperative complications of thyroidectomy for differentiated thyroid carcinoma (2004) Am J Otolaryngol., 25, pp. 225-230
dc.descriptionDutenhefner, S.E., Marui, S., Santos, A.B., Lima, E.U., Inoue, M., Neto, J.D., BRAF, a tool in the decision to perform elective neck dissection? (2013) Thyroid., , (in press)
dc.descriptionJoo, J.Y., Park, J.Y., Yoon, Y.H., Choi, B., Kim, J.M., Jo, Y.S., Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: A prospective study (2012) J Clin Endocrinol Metab., 97, pp. 3996-4003
dc.descriptionAkslen, L.A., LiVolsi, V.A., Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma (2000) Cancer., 88, pp. 1902-1908
dc.descriptionLeboulleux, S., Rubino, C., Baudin, E., Caillou, B., Hartl, D.M., Bidart, J.M., Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis (2005) J Clin Endocrinol Metab., 90, pp. 5723-5729
dc.descriptionRandolph, G.W., Duh, Q.Y., Heller, K.S., LiVolsi, V.A., Mandel, S.J., Steward, D.L., The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension (2012) Thyroid., 22, pp. 1144-1152
dc.descriptionArslan, N., Ilgan, S., Serdengecti, M., Ozguven, M.A., Bayhan, H., Okuyucu, K., Post-surgical ablation of thyroid remnants with high-dose (131)I in patients with differentiated thyroid carcinoma (2001) Nucl Med Commun., 22, pp. 1021-1027
dc.descriptionRosario, P.W., Mineiro Filho, A.F., Prates, B.S., Silva, L.C., Calsolari, M.R., Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation (2012) Thyroid., 22, pp. 1140-1143
dc.descriptionRosário, P.W., Borges, M.A., Alves, M.F., Purisch, S., Padrão, E.L., Rezende, L.L., Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy (2006) Arq Bras Endocrinol Metabol., 50, pp. 909-913
dc.descriptionTaylor, T., Specker, B., Robbins, J., Sperling, M., Ho, M., Ain, K., Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma (1998) Ann Intern Med., 129, pp. 622-627
dc.descriptionRosário, P.W., Borges, M.A., Valadão, M.M., Vasconcelos, F.P., Rezende, L.L., Padrão, E.L., Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm? (2007) Thyroid., 17, pp. 1225-1228
dc.descriptionVaisman, F., Shaha, A., Fish, S., Tuttle, R., Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer (2011) Clin Endocrinol (Oxf)., 75, pp. 112-119
dc.descriptionMomesso, D.P., Vaisman, F., de Cordeiro Noronha Pessoa, C.H., Corbo, R., Vaisman, M., Small differentiated thyroid cancer: Time to reconsider clinical management and treatment (2012) Surg Oncol., 21, pp. 257-262
dc.descriptionHay, I.D., Management of patients with low-risk papillary thyroid carcinoma (2007) Endocr Pract., 13, pp. 521-533
dc.descriptionRosário, P.W., Xavier, A.C., Calsolari, M.R., Value of postoperative thyroglobulin and ultrasonography for the indication of ablation and 131I activity in patients with thyroid cancer and low risk of recurrence (2011) Thyroid., 21, pp. 49-53
dc.descriptionNascimento, C., Borget, I., Al Ghuzlan, A., Deandreis, D., Chami, L., Travagli, J.P., Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level (2011) Endocr Relat Cancer., 18, pp. R29-R40
dc.descriptionVaisman, A., Orlov, S., Yip, J., Hu, C., Lim, T., Dowar, M., Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma (2010) Head Neck., 32, pp. 689-698
dc.descriptionIbrahimpasic, T., Nixon, I.J., Palmer, F.L., Whitcher, M.M., Tuttle, R.M., Shaha, A., Undetectable thyroglobulin after total thyroidectomy in patients with low-and intermediate-risk papillary thyroid cancer-is there a need for radioactive iodine therapy? (2012) Surgery., 152, pp. 1096-1105
dc.relationArquivos Brasileiros de Endocrinologia e Metabologia
dc.rightsfechado
dc.sourceScopus
dc.titleThyroid Nodules And Differentiated Thyroid Cancer: Update On The Brazilian Consensus [nódulo Tireoidiano E Câncer Diferenciado De Tireoide: Atualização Do Consenso Brasileiro]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución